(Q35703796)

9 August 2017

title

No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception (English)

1 reference

9 August 2017

0 references

anti-retroviral agent

0 references

16

Christine Rouzioux

0 references

Catherine Dollfus

4

object named as

Catherine Dollfus

0 references

Sophie Matheron

object named as

Sophie Matheron

7

0 references

Josiane Warszawski

17

object named as

Josiane Warszawski

1 reference

9 August 2017

18

Stéphane Blanche

1 reference

9 August 2017

2

Roland Tubiana

1 reference

9 August 2017

1

Laurent Mandelbrot

1 reference

9 August 2017

5

Albert Faye

1 reference

9 August 2017

3

Jerome Le Chenadec

1 reference

9 August 2017

Catherine Dollfus

4

1 reference

9 August 2017

Emmanuelle Pannier

6

1 reference

9 August 2017

Marie-Aude Khuong

8

1 reference

9 August 2017

Valerie Garrait

9

1 reference

9 August 2017

Veronique Reliquet

10

1 reference

9 August 2017

Alain Devidas

11

1 reference

9 August 2017

Alain Berrebi

12

1 reference

9 August 2017

Christine Allisy

13

1 reference

9 August 2017

Christophe Elleau

14

1 reference

9 August 2017

Cedric Arvieux

15

1 reference

9 August 2017

ANRS-EPF Study Group

19

1 reference

9 August 2017

language of work or name

English

0 references

publication date

21 July 2015

1 reference

Clinical Infectious Diseases

9 August 2017

published in

1 reference

9 August 2017

volume

61

1 reference

9 August 2017

issue

11

1 reference

9 August 2017

page(s)

1715-1725

1 reference

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

A national review of vertical HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Prevention of HIV-1 infection with early antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

British HIV Association guidelines for the management of HIV infection in pregnant women 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV578

21 January 2018

Identifiers

DOI

10.1093/CID/CIV578

1 reference

release_4h4dcsc5tzb7dk7t6phrgndt2e

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4h4dcsc5tzb7dk7t6phrgndt2e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference